TY - JOUR
T1 - Clinical implications of human papillomavirus in head and neck cancers
AU - Fakhry, Carole
AU - Gillison, Maura L.
PY - 2006/6/10
Y1 - 2006/6/10
N2 - Human papillomavirus (HPV) is now recognized to play a role in the pathogenesis of a subset of head and neck squamous cell carcinomas (HNSCCs), particularly those that arise from the lingual and palatine tonsils within the oropharynx. High-risk HPV16 is identified in the overwhelming majority of HPV-positive tumors, which have molecular-genetic alterations indicative of viral oncogene function. Measures of HPV exposure, including sexual behaviors, seropositivity to HPV16, and oral, high-risk HPV infection, are associated with increased risk for oropharyngeal cancer. HPV infection may be altering the demographics of HNSCC patients, as these patients tend to be younger, nonsmokers, and nondrinkers. There is sufficient evidence to conclude that a diagnosis of HPV-positive HNSCC has significant prognostic implications; these patients have at least half the risk of death from HNSCC when compared with the HPV-negative patient. The HPV etiology of these tumors may have future clinical implications for the diagnosis, therapy, screening, and prevention of HNSCC.
AB - Human papillomavirus (HPV) is now recognized to play a role in the pathogenesis of a subset of head and neck squamous cell carcinomas (HNSCCs), particularly those that arise from the lingual and palatine tonsils within the oropharynx. High-risk HPV16 is identified in the overwhelming majority of HPV-positive tumors, which have molecular-genetic alterations indicative of viral oncogene function. Measures of HPV exposure, including sexual behaviors, seropositivity to HPV16, and oral, high-risk HPV infection, are associated with increased risk for oropharyngeal cancer. HPV infection may be altering the demographics of HNSCC patients, as these patients tend to be younger, nonsmokers, and nondrinkers. There is sufficient evidence to conclude that a diagnosis of HPV-positive HNSCC has significant prognostic implications; these patients have at least half the risk of death from HNSCC when compared with the HPV-negative patient. The HPV etiology of these tumors may have future clinical implications for the diagnosis, therapy, screening, and prevention of HNSCC.
UR - http://www.scopus.com/inward/record.url?scp=33748155274&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33748155274&partnerID=8YFLogxK
U2 - 10.1200/JCO.2006.06.1291
DO - 10.1200/JCO.2006.06.1291
M3 - Review article
C2 - 16763272
AN - SCOPUS:33748155274
SN - 0732-183X
VL - 24
SP - 2606
EP - 2611
JO - Journal of Clinical Oncology
JF - Journal of Clinical Oncology
IS - 17
ER -